Research development of novel antineoplastic agents
Wada, T.; Matsui, H.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
2013
ISSN/ISBN: 0015-5691 PMID: 24369542 Document Number: 669771
Document emailed within 1 workday
Related Documents
Krepelka, J. 1987: Major trends in research of antineoplastic chemotherapeutic agents in Czechoslovakia Casopis Lekaru Ceskych 126(33): 1026-1030Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839
Endo, I.; Matsumoto, T. 2007: New bone density conservation agents for osteoporosis under research and development: PTH (1-34) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 443-446
Fujitani, Y. 2013: Strategy for research development of therapeutic agents for autoimmune diseases Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 57
Wada, S.; Fukawa, T.; Kamiya, S. 2007: New bone density conservation agents for osteoporosis under research and development: Zoledronate Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 421-425
Human Reproduction Unit World Health Organization 1973: Who task forces for research and development of fertility regulating agents a status report Contraception 8(1): 0-79
Siwi, B.H.; Ismail, I.G.; Basa, I.; Syarifuddin, A.; Arifin, M.S.; Djauhari, A.; Syam, M.; Mundy, P.; McIntosh, J.L. 1986: Cropping systems research in Indonesia. In: With our own hands. Research for Third World development: Canada's contribution through the International Development Research Centre 1970-1985 Publication, International Development Research Centre, Canada (IDRC-246e): 157-172
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Sakurai, Y. 1975: Deveolpment of new antineoplastic agents and their clinical characteristics Nihon Rinsho. Japanese Journal of Clinical Medicine 33(5): 1892-1896
Takeuchi, A. 1980: Bronchial artery infusion of antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2683-2690
Orfi, L.; Wáczek, F.; Szabó, M.; Kövesdi, I.; Mészáros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G.; Noszál, B. 1999: Preparation and characterization of potential antineoplastic agents Acta Pharmaceutica Hungarica 69(3): 115-122
Le Guern, M. 1987: DNA-topoisomerase II: Cellular targets of antineoplastic agents Pathologie-Biologie 35(4): 343-345
Kato, T.; Nemoto, R. 1982: Clinical application of microencapsulated antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 40(2): 478-488
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3